{"id":"https://openalex.org/W6889828759","doi":"https://doi.org/10.26181/27368043","title":"Asymmetric Membrane Floating Microspheres for Enhanced Anti-Inflammatory and Sustained Release of Ibuprofen","display_name":"Asymmetric Membrane Floating Microspheres for Enhanced Anti-Inflammatory and Sustained Release of Ibuprofen","publication_year":2024,"publication_date":"2024-10-01","ids":{"openalex":"https://openalex.org/W6889828759","doi":"https://doi.org/10.26181/27368043"},"language":"en","primary_location":{"id":"pmh:oai:figshare.com:article/27368043","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Asymmetric_Membrane_Floating_Microspheres_for_Enhanced_Anti-Inflammatory_and_Sustained_Release_of_Ibuprofen/27368043","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Text"},"volume":null,"type":"article","indexed_in":["datacite"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://figshare.com/articles/journal_contribution/Asymmetric_Membrane_Floating_Microspheres_for_Enhanced_Anti-Inflammatory_and_Sustained_Release_of_Ibuprofen/27368043","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Philip, Anil","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Philip, Anil","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112678484","display_name":"Betty Annie Samuel","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Samuel, Betty Annie","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025761854","display_name":"Bassim I. Mohammad","orcid":"https://orcid.org/0000-0001-6732-5940","observed_orcids":["https://orcid.org/0000-0001-6732-5940"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mohammad, Bassim","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5128665746","display_name":"Hayder Al-Aubaidy","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I196829312","display_name":"La Trobe University","ror":"https://ror.org/01rxfrp27","country_code":"AU","type":"education","lineage":["https://openalex.org/I196829312"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Al-Aubaidy, Hayder","raw_affiliation_strings":["La Trobe University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"La Trobe University","institution_ids":["https://openalex.org/I196829312"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.1458,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.44092651,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":90,"max":94},"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":true,"primary_topic":{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.9897000193595886,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.9897000193595886,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.00860000029206276,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ibuprofen","display_name":"ibuprofen","score":0.9980000257492065},{"id":"https://openalex.org/keywords/floating-drug-delivery-systems","display_name":"floating drug delivery systems","score":0.7450000047683716},{"id":"https://openalex.org/keywords/sustained-release","display_name":"sustained drug release","score":0.7950000166893005},{"id":"https://openalex.org/keywords/gastric-retention","display_name":"gastric retention","score":0.7239999771118164},{"id":"https://openalex.org/keywords/poorly-water-soluble-drugs","display_name":"poorly water-soluble drugs","score":0.9430000185966492},{"id":"https://openalex.org/keywords/drug-solubility-enhancement","display_name":"drug solubility enhancement","score":0.7670000195503235},{"id":"https://openalex.org/keywords/phase-inversion","display_name":"phase inversion","score":0.6650000214576721},{"id":"https://openalex.org/keywords/higuchi-kinetics","display_name":"Higuchi model","score":0.7059999704360962},{"id":"https://openalex.org/keywords/fickian-diffusion","display_name":"Fickian diffusion","score":0.9070000052452087},{"id":"https://openalex.org/keywords/anti-inflammatory-activity","display_name":"anti-inflammatory activity","score":0.9100000262260437},{"id":"https://openalex.org/keywords/drug-bioavailability","display_name":"drug bioavailability","score":0.7390000224113464},{"id":"https://openalex.org/keywords/gastrointestinal-side-effects","display_name":"gastrointestinal adverse effects","score":0.4339999854564667}],"concepts":[{"id":"https://openalex.org/C2779944601","wikidata":"https://www.wikidata.org/wiki/Q186969","display_name":"Ibuprofen","level":2,"score":0.7293000221252441},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6931999921798706},{"id":"https://openalex.org/C181389837","wikidata":"https://www.wikidata.org/wiki/Q461809","display_name":"Bioavailability","level":2,"score":0.6312999725341797},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.5511000156402588},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.5353000164031982},{"id":"https://openalex.org/C189942447","wikidata":"https://www.wikidata.org/wiki/Q61186","display_name":"Microsphere","level":2,"score":0.5327000021934509},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4578999876976013},{"id":"https://openalex.org/C2779820397","wikidata":"https://www.wikidata.org/wiki/Q1392806","display_name":"Drug delivery","level":2,"score":0.44440001249313354},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.4343999922275543},{"id":"https://openalex.org/C41625074","wikidata":"https://www.wikidata.org/wiki/Q176088","display_name":"Membrane","level":2,"score":0.3986999988555908},{"id":"https://openalex.org/C125287762","wikidata":"https://www.wikidata.org/wiki/Q1758948","display_name":"Absorption (acoustics)","level":2,"score":0.35989999771118164},{"id":"https://openalex.org/C163588942","wikidata":"https://www.wikidata.org/wiki/Q5165929","display_name":"Controlled release","level":2,"score":0.3463999927043915},{"id":"https://openalex.org/C134121241","wikidata":"https://www.wikidata.org/wiki/Q899301","display_name":"Yield (engineering)","level":2,"score":0.3416999876499176},{"id":"https://openalex.org/C13245373","wikidata":"https://www.wikidata.org/wiki/Q3715494","display_name":"Drug carrier","level":3,"score":0.32989999651908875},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.3165000081062317},{"id":"https://openalex.org/C69357855","wikidata":"https://www.wikidata.org/wiki/Q163214","display_name":"Diffusion","level":2,"score":0.3149000108242035},{"id":"https://openalex.org/C2992767386","wikidata":"https://www.wikidata.org/wiki/Q85739514","display_name":"Absorption rate","level":2,"score":0.3082999885082245},{"id":"https://openalex.org/C136229726","wikidata":"https://www.wikidata.org/wiki/Q327092","display_name":"Biomedical engineering","level":1,"score":0.30230000615119934},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.29789999127388},{"id":"https://openalex.org/C42360764","wikidata":"https://www.wikidata.org/wiki/Q83588","display_name":"Chemical engineering","level":1,"score":0.28540000319480896},{"id":"https://openalex.org/C2779429693","wikidata":"https://www.wikidata.org/wiki/Q274959","display_name":"Distilled water","level":2,"score":0.28369998931884766},{"id":"https://openalex.org/C3019981671","wikidata":"https://www.wikidata.org/wiki/Q5165929","display_name":"Immediate release","level":2,"score":0.2784000039100647},{"id":"https://openalex.org/C12554922","wikidata":"https://www.wikidata.org/wiki/Q7100","display_name":"Biophysics","level":1,"score":0.27489998936653137},{"id":"https://openalex.org/C77281830","wikidata":"https://www.wikidata.org/wiki/Q718608","display_name":"Dosage form","level":2,"score":0.2621000111103058},{"id":"https://openalex.org/C26291073","wikidata":"https://www.wikidata.org/wiki/Q310484","display_name":"Ex vivo","level":3,"score":0.26109999418258667},{"id":"https://openalex.org/C3020385749","wikidata":"https://www.wikidata.org/wiki/Q5165929","display_name":"Extended release","level":2,"score":0.2563000023365021}],"mesh":[],"locations_count":3,"locations":[{"id":"pmh:oai:figshare.com:article/27368043","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Asymmetric_Membrane_Floating_Microspheres_for_Enhanced_Anti-Inflammatory_and_Sustained_Release_of_Ibuprofen/27368043","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Text"},{"id":"doi:10.26181/27368043","doi":"https://doi.org/10.26181/27368043","is_oa":true,"landing_page_url":"https://doi.org/10.26181/27368043","pdf_url":null,"source":{"id":"https://openalex.org/S7407052018","display_name":"La Trobe University","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I196829312","host_organization_name":"La Trobe University","host_organization_lineage":["https://openalex.org/I196829312"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":null,"raw_source_name":null,"raw_type":"JournalArticle"},{"id":"doi:10.26181/27368043.v1","doi":"https://doi.org/10.26181/27368043.v1","is_oa":true,"landing_page_url":"https://doi.org/10.26181/27368043.v1","pdf_url":null,"source":{"id":"https://openalex.org/S7407052018","display_name":"La Trobe University","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I196829312","host_organization_name":"La Trobe University","host_organization_lineage":["https://openalex.org/I196829312"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":null,"raw_source_name":null,"raw_type":"JournalArticle"}],"best_oa_location":{"id":"pmh:oai:figshare.com:article/27368043","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Asymmetric_Membrane_Floating_Microspheres_for_Enhanced_Anti-Inflammatory_and_Sustained_Release_of_Ibuprofen/27368043","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Text"},"sustainable_development_goals":[{"score":0.8560000061988831,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"score":0.6491987109184265,"display_name":"Clean water and sanitation","id":"https://metadata.un.org/sdg/6"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":[],"abstract_inverted_index":{"Poorly":[0],"water-soluble":[1],"drugs":[2],"like":[3],"ibuprofen":[4],"present":[5],"challenges":[6],"related":[7],"to":[8,82,89,127,159,178],"limited":[9],"absorption":[10],"and":[11,35,65,108,136,182],"gastrointestinal":[12],"(GI)":[13],"side":[14],"effects.":[15,44],"This":[16,76],"work":[17],"aims":[18],"at":[19],"preparing":[20],"asymmetric":[21],"membrane":[22,69],"floating":[23],"microspheres":[24,59,81,99],"(AMFM)":[25],"with":[26,149,161],"the":[27,31,56,80,94,121,165,174],"purpose":[28],"of":[29,38,58,104,130,147,155,173],"enhancing":[30],"solubility,":[32],"gastric":[33,85,95],"retention,":[34],"therapeutic":[36],"efficiency":[37],"ibuprofen,":[39],"thereby":[40,92],"decreasing":[41],"its":[42],"adverse":[43],"Ibuprofen-AMFM":[45],"were":[46],"prepared":[47],"by":[48,72],"a":[49,61,66,128,187],"phase":[50],"inversion":[51],"technique,":[52],"which":[53],"resulted":[54],"in":[55,84,152],"formation":[57],"containing":[60],"porous":[62],"inner":[63],"layer":[64],"non-porous":[67],"outer":[68],"as":[70],"evidenced":[71],"scanning":[73],"electron":[74],"microscopy.":[75],"special":[77],"structure":[78],"allowed":[79],"float":[83],"fluid":[86],"for":[87,191],"up":[88,126],"12":[90,131],"hours,":[91],"increasing":[93],"residence":[96],"time.":[97],"The":[98],"showed":[100],"high":[101],"drug":[102,116,122,180],"loading":[103],"89.52":[105],"\u00b1":[106,112],"1.23%":[107],"process":[109],"yield":[110],"74.23":[111],"0.65%.":[113],"In":[114,139],"vitro":[115],"release":[117,123],"studies":[118,142],"indicated":[119,168],"that":[120,169],"gets":[124],"extended":[125],"period":[129],"hours":[132],"through":[133],"Fickian":[134],"diffusion":[135],"Higuchi":[137],"kinetics.":[138],"vivo":[140],"anti-inflammatory":[141],"also":[143],"demonstrated":[144],"increased":[145],"efficacy":[146],"ibuprofen-AMFM,":[148],"an":[150],"increase":[151],"inflammation":[153],"inhibition":[154],"about":[156],"85.34%,":[157],"compared":[158],"60.92%":[160],"pure":[162],"ibuprofen.":[163],"All":[164],"above":[166],"observations":[167],"ibuprofen-AMFM":[170],"was":[171],"one":[172],"most":[175],"efficient":[176],"ways":[177],"improve":[179],"bioavailability":[181],"patient":[183],"compliance,":[184],"hence":[185],"being":[186],"prospective":[188],"delivery":[189],"system":[190],"poorly":[192],"soluble":[193],"drugs.https://ecronicon.net/ecpt/asymmetric-membrane-floating-microspheres-for-enhanced-anti-inflammatory-and-sustained-release-of-ibuprofen":[194]},"counts_by_year":[{"year":2025,"cited_by_count":1}],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2025-10-10T00:00:00"}